AB
XFOR icon

Amalgamated Bank’s X4 Pharmaceuticals XFOR Stock Holding History

Amalgamated Bank’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-138
Closed -$1K – 3162
2025
Q1 		$1K Hold
138
– – ﹤0.01% 2938
2024
Q4 		$3K Hold
138
– – ﹤0.01% 2887
2024
Q3 		$3K Hold
138
– – ﹤0.01% 2913
2024
Q2 		$2K Hold
138
– – ﹤0.01% 2969
2024
Q1 		$6K Sell
138
-332
-71% -$9.24K ﹤0.01% 2683
2023
Q4 		$12K Sell
470
-41
-8% -$997 ﹤0.01% 2837
2023
Q3 		$17K Hold
511
– – ﹤0.01% 2741
2023
Q2 		$30K Buy
+511
New +$26.3K ﹤0.01% 2534

Other funds holding XFOR

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Amalgamated Bank's XFOR Position: Q2 2025 in Review

Amalgamated Bank sold out of X4 Pharmaceuticals (XFOR) in Q2 2025, closing a stake of 138 shares — an estimated $1K sold.

Amalgamated Bank first reported a position in XFOR in Q2 2023 and held it in 8 quarters. The position peaked at $30K in Q2 2023. 51 funds tracked by Wall St. Rank hold XFOR as of Q2 2025.

  • Amalgamated Bank reported no remaining X4 Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Amalgamated Bank sold 138 X4 Pharmaceuticals shares in Q2 2025, an estimated $1K.
  • Amalgamated Bank first reported a position in X4 Pharmaceuticals in Q2 2023 and held it in 8 quarters.
  • Amalgamated Bank's X4 Pharmaceuticals position peaked at $30K in Q2 2023.
  • 51 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q2 2025.

Based on Amalgamated Bank's 13F filing for Q2 2025, filed 4 Aug 2025.